leisure time
Previous article:
Moonlake's readout produced a cash windfall. Risks remain
Next article: Will the IRA bring competition to the biologics market?
Next article: Will the IRA bring competition to the biologics market?
explore
explore
-
Generate Biomedicines machine learning biotech raises $273M
2025-10-02 10:36 -
Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era
2025-10-02 10:00 -
Private equity could exacerbate cardiology's overuse problem, experts fear
2025-10-02 09:58 -
FDA approves updated Covid vaccines
2025-10-02 09:45 -
What to make of Biden’s latest efforts on cancer research
2025-10-02 09:39 -
Acelyrin, a rare IPO success, stumbles in its first big test
2025-10-02 08:28